Jang Na-ra

News and Video Search Results

News coverage

Novartis Fabhalta® (iptacopan) receives positive CHMP opinion as first oral monotherapy for adult patients with paroxysmal nocturnal hemoglobinuria (PNH)

GlobeNewswire 22 Mar 2024

· Positive CHMP opinion based on robust Phase III data, including APPLY-PNH, demonstrating superior hemoglobin improvement in the..

Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® (iptacopan) in adults with paroxysmal nocturnal hemoglobinuria (PNH)
GlobeNewswire 11 Dec 2023
Novartis receives FDA approval for Fabhalta® (iptacopan), offering superior hemoglobin improvement in the absence of transfusions as the first oral monotherapy for adults with PNH
GlobeNewswire 06 Dec 2023
Novartis Phase III APPOINT-PNH trial shows investigational oral monotherapy iptacopan improves hemoglobin to near-normal levels, leading to transfusion independence in all treatment-naïve PNH patients
GlobeNewswire 26 Apr 2023
Novartis presents pivotal Phase III APPLY-PNH data at ASH demonstrating investigational oral monotherapy iptacopan superiority over anti-C5
GlobeNewswire 13 Dec 2022

0 shares 1 views

You might like

Jang Na-ra media coverage

OH! HAPPY DAY Movie - JANG Na-ra, PARK Jung-chul

OH! HAPPY DAY Movie - JANG Na-ra, PARK Jung-chul

OH! HAPPY DAY Movie trailer - Director: YOON Hak-ryul
Genre: Romance, Comedy
Cast: JANG Na-ra, PARK Jung-chul

Teaser Trailer 22 May 2020

Novartis investigational iptacopan provides clinically meaningful increases in hemoglobin levels in complement-inhibitor-naïve patients with PNH

· Phase III APPOINT-PNH study of investigational oral monotherapy iptacopan met its primary endpoint; second positive Phase III..

GlobeNewswire 08 Dec 2022